
- Telehealth Visits
- Insurance plan information


Vineeta Singh, MD
Neurology • Vascular Neurology- Telehealth Visits
- Insurance plan information




Vineeta Singh, MD
Neurology • Vascular Neurology- Telehealth Visits
- Insurance plan information
On this page
Education & training
Board certification
- Neurocritical Care, American Board of Psychiatry and Neurology
- Vascular Neurology, American Board of Psychiatry and Neurology
- Neurology, American Board of Psychiatry and Neurology
Fellowship
- Critical Care Internship, UCSF Graduate Medical Education
Residency
- Neurology, Allegheny Univ of Hlth Scences
Internship
- Internal Medicine, Mercy Fitzgerald Hospital / Mercy Catholic Med Ctr
Degree
- MD, Institute of Medical Sciences Varanasi
My expertise
Specialties
- Neurology
- Vascular Neurology
Component Name: Provider Research Listing component built but no clinical trials or publications to display
Clinical Trials query: q=health_gateway_id_ss%3A%28%22697%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%22697%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.